Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9572862
Methods for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
granted -
US 9572828
Treatment for melanoma
granted -
US 9572881
Halogenated compounds for photodynamic therapy
granted -
US 9572873
Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins
granted -
US 9572870
Delivery of therapeutic compounds to the brain and other tissues
granted -
US 9572802
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted -
US 9574004
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 9572809
Combination therapy to treat Mycobacterium diseases
granted -
US 9573908
Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios
granted -
US 9573948
Triazolopyridine compounds and methods for the treatment of cystic fibrosis
granted -
US 9573906
Therapeutic compounds
granted -
US 9574211
Methods and compositions for prevention or treatment of a disease
granted -
US 9567402
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted -
US 9567566
HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
granted -
US 9566250
Artificial tissue constructs comprising alveolar cells and methods for using the same
granted -
US 9566295
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 9566310
Methods of treating muscular dystrophy
granted -
US 9566348
Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes
granted -
US 9567345
Pharmaceutically active pyrazolo-triazine derivatives
granted -
US 9567592
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
granted -
US 9565857
Antimicrobial solutions
granted -
US 9565840
Fibrotic non-human animal, and use thereof
granted -
US 9568476
Diagnosis and treatment of breast cancer
granted -
US 9567643
Compositions and methods for treating cancers
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.